Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.86%
#2 Pons Pons +33.93%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.17%
#4 Starpower Starpower +28.77%
#5 SkyAI SkyAI +23.54%
#6 TENDIES TENDIES +23.41%
#7 Mubarak Mubarak +22.85%
#8 StonkBroker StonkBroker +21.88%
#9 Ocean Protocol Ocean Protocol +21.10%
#10 PondCoin PondCoin +20.54%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Aton Aton

Aton

ALTAO
Kedudukan dalam Saham #30174
Based in France, Aton operates as a bioscience enterprise, with its... Based in France, Aton operates as a bioscience enterprise, with its headquarters located in Strasbourg. Established in 1998, the company's extensive operations encompass pharmaceutical research and development, the provision of preclinical and clinical services, and the creation of monoclonal antibodies. Additionally, Aton manufactures laboratory equipment, designs and produces various medical devices—including specialized surgical instruments powered by Stemcis technology—and supplies human tissues.
Harga Saham
$0.01779233
Modal Pasaran
$17.93M
Perubahan (1 hari)
-10.71%
Perubahan (1 tahun)
90.89%
Negara
FR
Perdagangan Aton (ALTAO)

Kategori

Healthcare
Nisbah P/B bagi Aton (ALTAO)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Aton, nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Aton dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH